Real-world data of cardiotoxicity during long-term therapy with trastuzumab in human epidermal growth factor receptor-2-positive metastatic breast cancer

Real-world data of cardiotoxicity during long-term therapy with trastuzumab in human epidermal growth factor receptor-2-positive metastatic breast cancer

Introduction/Objective. This study aims to investigate the cardiotoxicity of long-term therapy with trastuzumab in patients with HER-2-positive metastatic breast cancer. Methods. A total of 48 patients with metastatic HER-2-positive breast cancer were analyzed. The patients received long-term trastu...

Full description

Bibliographic Details
Main Authors: Iljovska Marina, Lazareva Emilija, Smichkoska Snezhana, Klisarovska Violeta, Stojkovski Igor, Petkovska Gordana, Mitreski Nenad
Format: Article
Language:English
Published: Serbian Medical Society 2023-01-01
Series:Srpski Arhiv za Celokupno Lekarstvo
Subjects:
breast cancer
cardiotoxicity
ejection fraction
safety
trastuzumab
Online Access:http://www.doiserbia.nb.rs/img/doi/0370-8179/2023/0370-81792200113I.pdf

Internet

http://www.doiserbia.nb.rs/img/doi/0370-8179/2023/0370-81792200113I.pdf

Similar Items